Zobrazeno 1 - 10
of 20
pro vyhledávání: '"L Lockridge"'
Autor:
Jennifer L Lockridge, Xiuxu Chen, Ying Zhou, Deepika Rajesh, Drew A Roenneburg, Subramanya Hegde, Sarah Gerdts, Tan-Yun Cheng, Regan J Anderson, Gavin F Painter, D Branch Moody, William J Burlingham, Jenny E Gumperz
Publikováno v:
PLoS ONE, Vol 6, Iss 6, p e21701 (2011)
CD1 molecules are glycoproteins that present lipids and glycolipids for recognition by T cells. CD1-dependent immune activation has been implicated in a wide range of immune responses, however, our understanding of the role of this pathway in human d
Externí odkaz:
https://doaj.org/article/c32569081ef64fd7a9252970b7d1d093
Autor:
Lisa M Fox, Daryl G Cox, Jennifer L Lockridge, Xiaohua Wang, Xiuxu Chen, Louise Scharf, David L Trott, Rachel M Ndonye, Natacha Veerapen, Gurdyal S Besra, Amy R Howell, Mark E Cook, Erin J Adams, William H Hildebrand, Jenny E Gumperz
Publikováno v:
PLoS Biology, Vol 7, Iss 10, p e1000228 (2009)
Natural killer T (NKT) cells are a subset of T lymphocytes with potent immunoregulatory properties. Recognition of self-antigens presented by CD1d molecules is an important route of NKT cell activation; however, the molecular identity of specific aut
Externí odkaz:
https://doaj.org/article/3f5a22c8a7f44061b89d85e01ac33a7a
Autor:
Rajiv Agarwal, Talal Alfaadhel, Martin J. Andersen, John Robert Asplin, Rupali S. Avasare, George L. Bakris, Amar D. Bansal, Pravir V. Baxi, Michael Berkoben, Scott D. Bieber, Florian Buchkremer, Anna Marie Burgner, James Brian Byrd, Daniel Cattran, Devasmita Choudhury, Rolando Claure-Del Granado, Bradley M. Denker, Vimal K. Derebail, Robert J. Desnick, Luca di Lullo, John V. Duronville, Garabed Eknoyan, Mina El Kateb, William J. Elliott, Jennifer L. Ennis, Fernando C. Fervenza, Robert A. Figlin, Zita Galvin, Pranav S. Garimella, Debbie S. Gipson, Patrick E. Gipson, David S. Goldfarb, Arthur Greenberg, Hermann Haller, Swapnil Hiremath, Edward J. Horwitz, Susan Hou, Lesley A. Inker, Maria V. Irazabal, Ashley Bruce Irish, Kenar D. Jhaveri, Jonathan Ashley Jefferson, Kamyar Kalantar-Zadeh, Elaine S. Kamil, Jon-Emile S. Kenny, Charbel C. Khoury, Jatinder Kohli, Eugene C. Kovalik, Csaba P. Kovesdy, Warren Kupin, Ruediger W. Lehrich, Edgar V. Lerma, Moshe Levi, Joseph L. Lockridge, Jennifer Lopez, Etienne Macedo, Rajnish Mehrotra, Ravindra L. Mehta, Patrick H. Nachman, Carol Nadai, Lavinia Aura Negrea, Lindsay E. Nicolle, Keith C. Norris, Alexander Novakovic, Ali J. Olyaei, Sumanta Kumar Pal, Paul M. Palevsky, Ami M. Patel, Vikram Patney, Mark A. Perazella, Phuong-Chi T. Pham, Phuong-Thu T. Pham, Joseph B. Pryor, C. Venkata S. Ram, Mahboob Rahman, MD, Nathaniel Reisinger, Michael V. Rocco, Claudio Ronco, Mark E. Rosenberg, Mitchell H. Rosner, Michael R. Rudnick, Ernesto Sabath, Mark J. Sarnak, Jane O. Schell, N. Winn Seay, John R. Sedor, Akash Nair Sethi, Anuja Shah, Lori Shah, Benjamin A. Sherer, Harpreet Singh, Rajalingam Sinniah, James A. Sloand, Matthew A. Sparks, Stuart M. Sprague, Susan Patricia Steigerwalt, Hillel Sternlicht, Marshall L. Stoller, Beje Thomas, Hakan R. Toka, Joel M. Topf, Vicente E. Torres, Howard Trachtman, Carol Traynor, Bryan M. Tucker, Beth A. Vogt, Rimda Wanchoo, Matthew R. Weir, Adam Whaley-Connell, William L. Whittier, Jay B. Wish, Florence Wong, David C. Wymer, David T.G. Wymer, Ladan Zand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79fe2f8a060c7f93e83fad6515e76915
https://doi.org/10.1016/b978-0-323-47871-7.00004-6
https://doi.org/10.1016/b978-0-323-47871-7.00004-6
Autor:
Ying Zhou, Shannon C. Kenney, Christian M. Capitini, Jenny E. Gumperz, Yusof A. Becker, Annette Gendron-Fitzpatrick, Peiman Hematti, Shidong Ma, Jennifer L. Lockridge, William J. Burlingham
Publikováno v:
Biology of Blood and Marrow Transplantation. 19:1310-1322
Chronic graft-versus-host disease (cGVHD) is a significant roadblock to long-term hematopoietic stem cell (HSC) transplantation success. Effective treatments for cGVHD have been difficult to develop, in part because of a paucity of animal models that
Publikováno v:
Journal of Interactive Media in Education, Vol 2014, Iss 2 (2014)
Journal of Interactive Media in Education; Vol 2014, No 2: Newcastle OER 2014 (Special Issue); Art. 6
Journal of Interactive Media in Education; Vol 2014, No 2: Newcastle OER 2014 (Special Issue); Art. 6
This case study illustrates how DS106, a computer science course in Digital Storytelling from the University of Mary Washington (UMW) and accessible as an open course on the web, is being explored in a corporate environment at 3M, an American multina
Autor:
Jenny E. Gumperz, Shannon C. Kenney, Yusof A. Becker, Subramanya Hegde, Jennifer L. Lockridge, Shidong Ma
Publikováno v:
Journal of autoimmunity. 37(1)
NKT cells are innate lymphocytes that can recognize self or foreign lipids presented by CD1d molecules. NKT cells have been shown to inhibit the development of autoimmunity in murine model systems, however, the pathways by which they foster immune to
Autor:
Xiaohua Wang, Jenny E. Gumperz, Xiuxu Chen, Jennifer L. Lockridge, Natacha Veerapen, Mark E. Cook, William H. Hildebrand, Erin J. Adams, Rachel M. Ndonye, Louise Scharf, David L Trott, Amy R. Howell, Gurdyal S. Besra, Daryl Cox, Lisa M. Fox
Publikováno v:
PLoS Biology, Vol 7, Iss 10, p e1000228 (2009)
PLoS Biology
PLoS Biology
By identifying the lipid LPC as an endogenous antigen, recognized by the invariant subset of human NKT cells, this study establishes a novel link between these immunoregulatory cells and an inflammatory lipid mediator.
Natural killer T (NKT) cel
Natural killer T (NKT) cel
Autor:
PG Richardson, R Rosovsky, F Hong, D Tocco, B Connell, C Mitsiades, R Schlossman, IM Ghobrial, NC Munshi, L Lockridge, D Warren, G Bradwin, M Doyle, R Soiffer, KC Anderson, E Weller
Publikováno v:
Clinical Lymphoma and Myeloma. 9:S55
Autor:
D. Yoo, K. Teresa, L. Lockridge, P. Joseph, Devon Evans, C. Maia-Acuna, K. Demel, Howard Safran, Thomas J. Miner, David A. Iannitti
Publikováno v:
Journal of Clinical Oncology. 24:4002-4002
4002 Background: GW572016 is an orally active small molecule that reversibly inhibits ErbB1 and ErbB2 tyrosine kinases. ErbB1 is commonly expressed in pancreaticobiliary cancers. ErbB2 is the preferred heterodimer partner for other ErbB receptors. Ba